Jaundice pp 245-255 | Cite as

Hemolysis, Jaundice and Liver Disease

  • Michael C. Brain
Part of the Hepatology book series (H, volume 2)


Jaundice due to elevation of serum unconjugated bilirubin only becomes evident when hemolytic anemia causes a two to threefold or greater increase in hemoglobin catabolism. Even in rapid hemolysis, in which the production of bilirubin from hemoglobin reaches the maximum that can be handled of about six tijnes the normal rate in an adult of 7.5 grams of hemoglobin per day, the serum level of unconjugated bilirubin rarely rises above 3 to 5 milligrams per 100 ml (Powell, 1972).


Hemolytic Anemia Obstructive Jaundice Free Cholesterol Osmotic Fragility Lithocholic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    BERK PD, BLOOMER JR, HOWE RB, et al: Bilirubin production as a measure of red cell life span. J Lab Clin Med 79: 364–378, 1972.PubMedGoogle Scholar
  2. 2.
    BERK PD: Total body handling of bilirubin. In Jaundice, edited by C.A. Goresky and M.M. Fisher, New York, Plenum Press, 1975.Google Scholar
  3. 3.
    ’ BOULARD M, BLUME KG, BEUTLER E: The effect of copper on red cell enzyiæ activities. J Clin Invest 51: 459–461, 1972.PubMedCrossRefGoogle Scholar
  4. 4.
    CARR-SAUNDERS E, LAURANCE BM: Wilson’s disease presenting as an acute hemolytic anemia. Proc Roy Soc Med 58: 614–615, 1965Google Scholar
  5. 5.
    CHEUNG WH, SANITSKY A, ISENBERG HD: The effect of bilirubin on the mammalian erythrocyte. Transfusion 6: 475–486, 1966PubMedCrossRefGoogle Scholar
  6. 6.
    COLTMAN CA JR, DUDLEY GM III: The relationship between endogenous carbon monoxide production and total heme mass in normal and abnormal subjects. Am J Med Sci 258: 374–385, 1969CrossRefGoogle Scholar
  7. 7.
    COOPER RA, JANDL JH: Bile salts and cholesterol in the pathogenesis of target cells in obstructive jaundice. J Clin Invest 47: 809–822, 1968PubMedCrossRefGoogle Scholar
  8. 8.
    COOPER RA: Anemia with spur cells: A red cell defect acquired in serum and modified in the circulation. J Clin Invest48: 1820–1831, 1969PubMedCrossRefGoogle Scholar
  9. 9.
    COOPER RA, DILOY-PURAY M, LANDO P, et al: An analysis of lipoproteins, bile acids and red cell membranes associated with target cells and spur cells in patients with liver disease. J Clin Invest 51: 3182–3192, 1972.PubMedCrossRefGoogle Scholar
  10. 10.
    COOPER RA, GARCIA FA, TREY C: The effect of lithocholic acid on red cell membranes in vivo. J Lab Clin Med 79: 7–18, 1972PubMedGoogle Scholar
  11. 11.
    COOPER RA, KIMBAL DB, DUROCHER JR: Role of the spleen in membrane conditioning and hemolysis of spur cells in liver disease. New Eng J Med 290: 1279–1284, 1974PubMedCrossRefGoogle Scholar
  12. 12.
    DEISS A, LEE GR, CARTWRIGHT GE: Hemolytic anemia in Wilson’s disease. Ann Intern Med 73: 413–418, 1970PubMedGoogle Scholar
  13. 13.
    ENGSTEDT L: Endogenous formation of carbon monoxide in hemolytic disease. Acta Med Scand Suppl 159: (332) 1–63, 1957Google Scholar
  14. 14.
    JANDL JH: Anemia of liver disease: Observation on its mechanism. J Clin Invest 34: 390–404, 1955PubMedCrossRefGoogle Scholar
  15. 15.
    LANDAW SA: Carbon monoxide production as a measurement of heme catabolism. In Jaundice, edited by C.A. Goresky and M.M. Fisher, New York, Plenum Press, 1975.Google Scholar
  16. 16.
    MCINTYRE N, CLINK HM, LEVI AJ, et al: Hemolytic anemia in Wilson’s disease. New Eng J Med 276: 439–444, 1967PubMedCrossRefGoogle Scholar
  17. 17.
    MURPHY JR: Erythrocyte Metabolism III. Relationship of energy metabolism and serum factors to the osmotic fragility following incubation. J Lab Clin Med 60: 86–109, 1962Google Scholar
  18. 18.
    PERONA C, CORROCHER R, FREZZA M, et al: Phenobarbitone sensitivity of jaundice in haemolytic patients. Brit J Haemat 25: 723–736, 1973PubMedCrossRefGoogle Scholar
  19. 19.
    POWELL LW: Clinical aspects of unconjugated hyperbilirubinemia. Seminars Hemat 9: 91–105, 1972Google Scholar
  20. 20.
    ROBINS SJ, MILLER A: Red cell cholesterol depletion and the formation of speculated cells in vivo. J Lab Clin Med38: 436–450, 1974Google Scholar
  21. 21.
    TISDALE WA, KLATSKIN G, KINSELLA ED: The significance of the direct fraction of serum bilirubin in hemolytic jaundice. Am J Med 26: 214–227, 1959PubMedCrossRefGoogle Scholar
  22. 22.
    WALSHE JM: Wilson’s disease. The presenting symptoms. Arch Dis Childh 37: 253–256, 1962PubMedCrossRefGoogle Scholar
  23. 23.
    ZIEVE L: Jaundice hyperlipemia and hemolytic anemia. A heretofore unrecognized syndrome associated with alcohol fatty liver and cirrhosis. Ann Int Med 48: 471–496, 1958PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Michael C. Brain
    • 1
  1. 1.McMaster UniversityHamiltonCanada

Personalised recommendations